UNIVERSITY OF CHICAGO
New and Disruptive Therapeutic Approaches to Target Fundamental Molecular Mechanisms Underlying Atrial Fibrillation
New and Disruptive Therapeutic Approaches to Target Fundamental Molecular Mechanisms Underlying Atrial Fibrillation is a funding opportunity from UNIVERSITY OF CHICAGO, up to 964320, closing December 31, 2028.
Dec 31, 2028
(884d left)Overview
PROJECT SUMMARY Atrial fibrillation (AF) is the most common heart rhythm disorder that affects 3 million Americans and is a major cause of stroke. Since AF is primarily an age-related disease, it is fast becoming an epidemic in a rapidly aging population. Unfortunately, current therapeutic approaches to AF – both…